~11 spots leftby Feb 2026

SGN-ALPV for Cancer

Palo Alto (17 mi)
Age: 18+
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: Phase 1
Waitlist Available
Sponsor: Seagen Inc.
No Placebo Group

Trial Summary

What is the purpose of this trial?This trial is testing a new drug called SGN-ALPV in patients with advanced solid tumors. It aims to find the right dosage and see if the drug is safe and effective.

Eligibility Criteria

This trial is for adults with advanced solid tumors like stomach, cervical, testicular cancers and more. These tumors must be metastatic or unresectable. Participants need confirmed diagnoses and may require biopsies. They should not have had certain recent cancers or treatments that could interfere with the study.

Treatment Details

SGN-ALPV is being tested to determine its safety and effectiveness in treating various solid tumor cancers. The trial has three parts: Parts A and B will establish the proper dose; Part C will assess how safe it is at that dose and if it helps treat cancer.
1Treatment groups
Experimental Treatment
Group I: SGN-ALPVExperimental Treatment1 Intervention
SGN-ALPV monotherapy

Find a clinic near you

Research locations nearbySelect from list below to view details:
Virginia Cancer SpecialistsFairfax, VA
Ottawa Hospital Cancer CentreOttawa, Canada
University Health Network, Princess Margaret HospitalToronto, Canada
START Mountain RegionWest Valley City, UT
More Trial Locations
Loading ...

Who is running the clinical trial?

Seagen Inc.Lead Sponsor

References